About Ceza Formulations Private Limited
Data last updated:
Ceza Formulations Private Limited is a private limited company based in Indore, Madhya Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 26 March 1999 and has been in existence for over 27 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24232MP1999PTC013421. Its GSTIN is 23AACCC1848B1ZA (Madhya Pradesh). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹15 Lakh. It is led by directors including Narendra Kumar Dalawat and Mimoh Paliwal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 236 Sectore E. Sanwer Road Industrial Area, Indore, Madhya Pradesh, India – 452001.
As per the financials filed for FY 2024, the company reported a revenue of ₹3.6 Cr, a growth of 50% compared to the previous year. For the same year it recorded a net profit of ₹50,770 (net margin 0.1%) and EBITDA of ₹36.56 Lakh (EBITDA margin 10.1%). Revenue has declined at a compounded annual rate (CAGR) of 25% over three years and 3% over five years.
The company has about 8 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹78 Lakh and satisfied charges of ₹1.03 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website ceza-formulations-pl.business.site.
- EmailLocked
- TelephoneLocked
- Social MediaLocked
- Registered Address236 Sectore E. Sanwer Road Industrial Area, Indore, Madhya Pradesh, India – 452001
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Ceza Formulations Private Limited
The main business activity of Ceza Formulations is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Ceza Formulations Private Limited FY 2025 filings available
Ceza Formulations Private Limited reported revenue of ₹3.6 Cr (up 50% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Ceza Formulations Private Limited
Revenue rose 50% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 3%. EBITDA rose 130% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Ceza Formulations Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹36.56 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹50,770 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Ceza Formulations Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 10.1% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.1% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Ceza Formulations are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Auditor Details of Ceza Formulations Private Limited
Ceza Formulations Private Limited is audited by Nahata Mahajan & Co. for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Nahata Mahajan & Co. | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Ceza Formulations Private Limited
Ceza Formulations has 4 current directors and 8 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Narendra Kumar Dalawat | Director | 11 Jul 2016 | 10 Years 2 Months | Current |
| Mimoh Paliwal Also directs: Saji Exports LLP | Director | 10 Nov 2014 | 11 Years 10 Months | Current |
| Krishnakant Mundra Also directs: Exponential Export Solutions Private Limited | Director | 10 Nov 2014 | 11 Years 10 Months | Current |
| Anil Kumar Vyas Also directs: Mednext Pharma Private Limited, Alice Pharma Private Limited, Mednext Biotech Limited and 1 more | Director | 13 Dec 2014 | 11 Years 9 Months | Current |
Ownership and Shareholding of Ceza Formulations Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Ceza Formulations Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 Dec 2018 | Others | ₹78 Lakh | Open |
| 24 Oct 2016 | Others | ₹92.5 Lakh | Satisfied |
| 25 Apr 2001 | State Bank of India | ₹5 Lakh | Satisfied |
| 25 Apr 2001 | State Bank of Indore | ₹5 Lakh | Satisfied |
Total charge records: 4 View all charges
Employees and EPFO Compliance at Ceza Formulations Private Limited
Ceza Formulations Private Limited has a workforce of 8 employees as of Apr 06, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Ceza Formulations Private Limited
Ceza Formulations Private Limited has 12 board changes on record since 2011: 4 appointments and 8 cessations. The latest: Narendra Kumar Dalawat ceased to be Additional Director on 30 Sep 2016.
13 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Ceza Formulations Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Ceza Formulations Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Ceza Formulations Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Ceza Formulations Private Limited
Ceza Formulations has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AACCC1848B1ZA | Madhya Pradesh | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Ceza Formulations Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ceza Formulations Private Limited
Ceza Formulations is an active private limited company based in Indore, Madhya Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 26 March 1999 (27+ years old) and is registered under CIN U24232MP1999PTC013421.
Ceza Formulations reported revenue of ₹3.6 Cr for FY 2024 (up 50% YoY).
Ceza Formulations has 4 current directors:
- Narendra Kumar Dalawat - Director
- Mimoh Paliwal - Director
- Krishnakant Mundra - Director
- Anil Kumar Vyas - Director
Ceza Formulations reported a net profit of ₹50,770 (net margin 0.1%) and EBITDA of ₹36.56 Lakh (EBITDA margin 10.1%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Ceza Formulations is 25% over three years and -3% over five years. In the latest year (FY 2024) revenue rose 50%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Ceza Formulations is 23AACCC1848B1ZA, registered in Madhya Pradesh. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Ceza Formulations is U24232MP1999PTC013421. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ceza Formulations was incorporated on 26 March 1999, making it 27+ years old. It is registered with the Registrar of Companies, Gwalior.
Narendra Kumar Dalawat ceased to be Additional Director on 30 Sep 2016. Alex Charles Fernandes ceased to be Director on 18 Aug 2016. Narendra Kumar Dalawat was appointed as Director on 11 Jul 2016. Ceza Formulations has 12 board changes on record in total.
Ceza Formulations can be reached through the website ceza-formulations-pl.business.site. Its registered office is in Indore, Madhya Pradesh, India.